The history of the erectile dysfunction drug presents a complex picture for shareholders. While the initial launch generated substantial profits, the expiration of its patent opened the door to generic versions, dramatically diminishing market share. This creates a specific challenge for pharmaceutical companies depending on comparable blockbuster

The story of Viagra, and its creator copyright, presents a intriguing case study for investors. Initially a blockbuster drug, yielding billions in revenue , its patent expiration created a flood of generic competition , significantly impacting its position . While specific businesses may seek to capitalize on similar conditions , the current landsc